摘要
目的 探讨参松养心胶囊辅助治疗老年射血分数保留的心力衰竭（HFpEF）合并室性早搏的临床疗效及安全性。方法 选取2024年1月—2025年1月于我院老年 HFpEF 合并室性早搏患者70例，同时以均分的形式分入观察组与对照组。对照组给予常规抗心衰及抗心律失常治疗，观察组在对照组基础上加用参松养心胶囊治疗，疗程均为3个月。比较两组患者治疗效果。结果 治疗后，治疗总有效率观察组高于对照组（P<0.05）；治疗后，LVEF 观察组高于对照组，LVEDD、LVESD 观察组低于对照组（P<0.05）。室性早搏次数观察组少于对照组（P<0.05）生活质量评分观察组高于对照组（P<0.05）。结论 参松养心胶囊辅助治疗老年HFpEF合并室性早搏，可有效改善心功能，减少室性早搏发作，且安全性良好，值得临床推广应用。
关键词： 参松养心胶囊；射血分数保留的心力衰竭；室性早搏；老年患者；心功能
Abstract
Objective To investigate the clinical efficacy and safety of Shensong Yangxin Capsules as an adjuvant therapy for elderly heart failure with preserved ejection fraction (HFpEF) and ventricular premature beats. Methods 70 elderly patients with HFpEF and ventricular premature beats were selected from January 2024 to January 2025 in our hospital, and were divided into an observation group and a control group in an equal distribution manner. The control group received routine anti heart failure and anti arrhythmia treatment, while the observation group received additional treatment with Shensong Yangxin Capsules on the basis of the control group, with a treatment course of 3 months for both groups. Compare the treatment outcomes of two groups of patients. Results After treatment, the total effective rate of the observation group was higher than that of the control group (P<0.05); After treatment, the LVEF observation group was higher than the control group, while the LVEDD and LVESD observation groups were lower than the control group (P<0.05). The number of ventricular premature beats in the observation group was less than that in the control group (P<0.05), and the quality of life score in the observation group was higher than that in the control group (P<0.05). Conclusion Shensong Yangxin Capsules as an adjuvant therapy for elderly HFpEF patients with ventricular premature beats can effectively improve cardiac function, reduce ventricular premature beats, and have good safety. It is worthy of clinical promotion and application.
Key words： Shen Song Yang Xin Capsules; Heart failure with preserved ejection fraction; Premature ventricular contractions; Elderly patients; Cardiac function
参考文献 References
[1] 雒丽华,张晶,汪晓莹,等. 参松养心胶囊治疗老年慢性心力衰竭临床研究[J]. 中华中医药学刊,2024,42(6):169-173.
[2] 何文凤,薛成,郑健康,等. 参松养心胶囊联合沙库巴曲缬沙坦治疗阵发性心房颤动合并慢性心力衰竭对hs-CRP、BNP、AngⅡ及心功能的影响[J]. 中华中医药学刊,2024, 42(6):95-98.
[3] 周丽英,屠建平,张洁,等. 参松养心胶囊结合维生素B12对老年冠心病心力衰竭患者心功能参数及心肌损伤标志物的影响[J]. 辽宁中医杂志,2024,51(10):85-89.
[4] 王云菲,王联发,章帮助,等. 参松养心胶囊联合沙库巴曲缬沙坦钠治疗慢性心力衰竭合并室性心律失常对心室重塑、心功能分级和炎症因子水平的影响[J]. 中国医刊, 2024,59(10):1081-1085.
[5] 王丹,杨子琦. 参松养心胶囊对心力衰竭伴室性心律失常患者心功能及血浆N末端B型利钠肽原水平的影响[J]. 山西医药杂志,2024,53(8):602-604.
[6] 陈韵宇,赖国勇. 参松养心胶囊联合富马酸比索洛尔对心力衰竭合并室性早搏的疗效[J]. 西北药学杂志,2023, 38(4):137-141.
[7] 周小俊,宋雨,王涛. 参松养心胶囊对老年心力衰竭合并房颤患者心室重构、NT-proBNP及QTd的影响[J]. 老年医学与保健,2023,29(3):502-505,518.
[8] 刘盈盈,刘美丽,梁潇,等. 参松养心胶囊联合胺碘酮治疗慢性充血性心力衰竭伴室性心律失常疗效研究[J]. 湖北中医药大学学报,2023,25(6):22-25.
[9] 任佳悦,杨燕冰,张晓天. 参松养心胶囊联合胺碘酮治疗老年心律失常患者的临床效果及对内质网应激因子的影响[J]. 辽宁中医杂志,2024,51(6):135-137.
[10] 赖娟,王勉,邓霖,等. 参松养心胶囊联合阿托伐他汀钙片对超高危急性冠状动脉综合征患者的临床疗效[J]. 中成药,2024,46(7):2240-2243.